drugset / Trial / NCT03492515
Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia
Phase 3
Unknown
90 enrolled
Shandong University
First Affiliated Hospital of Chongqing Medical University · collabLinyi People's Hospital · collabPeking University People's Hospital · collabShandong Provincial Hospital · collabThe Affiliated Hospital of Qingdao University · collabZhongshan Bo Ai Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to observe the clinical efficacy and adverse reactions of rhTPO in the treatment of pregnancy-induced thrombocytopenia.
Timeline
- Start
- 2018-05-01
- Primary completion
- 2020-05-01
- Completion
- 2022-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | recombinant human thrombopoietin | Protein / enzyme biologic | 300 iu/kg | Subcutaneous |
| Comparator | Platelet Concentrate | Other / unclassified | — | — |